Brimonidine Tartrate
- Product NDC
- 25685-715
- 11-digit product format
- 256850715
- Labeler code
- 25685
- Product ID
- 25685-715_d3d9fdf9-b40f-4768-a1e3-63c13805c145
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- brimonidine tartrate
- Dosage form
- SOLUTION/ DROPS
- Route
- OPHTHALMIC
- Labeler
- Regimed Medical
- Application
- ANDA076439
- Marketing category
- ANDA
- Marketing start
- 2016-03-03
- Marketing end
- 0000-00-00
- Substance
- BRIMONIDINE TARTRATE
- Active strength
- 2 mg/mL
- Pharmacologic classes
- Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 25685-715-10 | 2022-05-24 | C162847 | 48780-1 | 9d75b9d0-cee3-f424-e053-dadaa90a57ce | 518b1ecc-e472-49aa-9e1c-2db668f34334 |
| 25685-715-11 | 2022-05-24 | C162847 | 48780-1 | 9d75b9d0-cee3-f424-e053-dadaa90a57ce | 518b1ecc-e472-49aa-9e1c-2db668f34334 |
| 25685-715-12 | 2022-05-24 | C162847 | 48780-1 | 9d75b9d0-cee3-f424-e053-dadaa90a57ce | 518b1ecc-e472-49aa-9e1c-2db668f34334 |
| 25685-715-10 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-cee3-f424-e053-dadaa90a57ce | 518b1ecc-e472-49aa-9e1c-2db668f34334 |
| 25685-715-11 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-cee3-f424-e053-dadaa90a57ce | 518b1ecc-e472-49aa-9e1c-2db668f34334 |
| 25685-715-12 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-cee3-f424-e053-dadaa90a57ce | 518b1ecc-e472-49aa-9e1c-2db668f34334 |